Coronavirus: How Are You Responding?
We want to hear from nurses what your institutions are doing to safeguard employees and patients against the coronavirus, as well as common patient questions you’ve been receiving.
Updated March 12, 2020 to include information about the ONS Congress and Extraordinary Healer.
It is nearly impossible to turn on the news without hearing about the coronavirus (COVID-19), as the number of cases—and geographical locations–affected by it continue to grow.
Coronavirus Affects Healthcare Professionals
The highly contagious disease may pose additional risks to nurses and other healthcare providers, leading to the FDA’s allowance of industrial-grade respirators to be used in healthcare settings.
Coronavirus is also affecting the oncology space by being the culprit behind cancelled and modified conferences. The Society for Gynecologic Oncology (SGO) nixed their International Session later this month.
Additionally, the Oncology Nursing Society (ONS) canceled their Annual Congress set to be held April 29-May 3 in San Antonio, Texas. In a statement, the society wrote, "We are disappointed that our community of nurses won’t be able to gather to connect and learn. However, we are investigating ways to share some of the content planned for this year’s Congress to our registrants and members in alternate formats or venues. More information will be shared about this as details are finalized."
With the cancellation of the ONS Congress also comes the cancellation of the 2020 Extraordinary Healer awards ceremony, hosted by Oncology Nursing News' sister publication, CURE. The event, which honors the amazing work of oncology nurses, was scheduled for Thursday, April 30. In an email to attendees, CURE Media Group wrote, "We hope to celebrate the wonderful accomplishments of this year’s award recipients at a later date. Currently registered attendees will receive an email notification with additional details once they become available. We appreciate your understanding of these extenuating circumstances and look forward to celebrating with you soon."
Coronavirus and Patients With Cancer
The virus can also be risky for patients with cancer—especially those with weakened immune systems.
We want to hear from nurses what your institutions are doing to safeguard employees and patients against the coronavirus, as well as common patient questions you’ve been receiving.
Share your input in our survey: https://www.surveymonkey.com/r/5BCQ2XR
Dual Checkpoint Inhibition Increases Response Rates, Adverse Effects in Melanoma
April 19th 2024Patients with high-risk resectable melanoma treated with ipilimumab plus nivolumab had increased response rates compared with anti-PD1 monotherapy, though it was also associated with increased immune-related adverse effects.
